PHF2P2: A Drug Target / Disease Biomarker (G100873793)

Target Name: PHF2P2

NCBI ID: G100873793

PHF2P2

Other Name(s): PHD finger protein 2 pseudogene 2

PHF2P2: A Drug Target / Disease Biomarker

PHF2P2, also known as interleukin-18 (IL-18), is a protein that is expressed in various tissues throughout the body, including the immune system, skin, and uterine lining. It is a key regulator of the immune response and has been implicated in a number of diseases, including cancer, autoimmune disorders, and obesity.

One of the key functions of PHF2P2 is its role in the regulation of inflammation. When the body is exposed to an infection or injury, PHF2P2 helps to coordinate the immune response by promoting the recruitment of immune cells to the site of injury or infection. This is accomplished through the interaction of PHF2P2 with its receptor, which is found on the surface of immune cells, including T cells, B cells, and natural killer cells.

PHF2P2 also plays a key role in the regulation of cellular processes that are important for tissue growth and development. For example, it has been shown to promote the production of new cells in various tissues, including the liver, and to regulate the cell cycle.

In addition to its role in inflammation and cellular growth, PHF2P2 is also a potential drug target. Researchers have identified several potential small molecules that can inhibit the activity of PHF2P2, and these molecules have been shown to have a variety of therapeutic effects, including the treatment of cancer, autoimmune disorders, and obesity.

One of the most promising of these drugs is a compound called Selinexys, which is a inhibitor of PHF2P2. In preclinical studies, Selinexys has been shown to have potent anti-inflammatory and anti-obesity effects, and it is currently being evaluated as a potential treatment for these conditions.

Another potential drug target for PHF2P2 is a molecule called resveratrol, which is a natural compound that is found in a variety of plants and animals, including red wine, grapes, and peanuts. Resveratrol has been shown to have a variety of therapeutic effects, including the inhibition of cancer growth and the regulation of cellular processes that are important for aging and disease.

Resveratrol is currently being investigated as a potential treatment for a variety of conditions, including cancer, obesity, and neurodegenerative disorders. In addition to its potential therapeutic effects, resveratrol is also being studied as a potential drug target for PHF2P2, and several studies have shown that it can inhibit the activity of PHF2P2 in preclinical settings.

Overall, PHF2P2 is a protein that is involved in a variety of important cellular processes in the body, including inflammation, tissue growth and development, and metabolism. Its potential as a drug target makes it an attractive target for the development of new therapies for a variety of conditions.

Protein Name: PHD Finger Protein 2 Pseudogene 2

The "PHF2P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PHF2P2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets